-
-
-
-
-
-
-
Takeda (TAK) Receives Positive CHMP Opinion for Recombinant ADAMTS13 (rADAMTS13) in Congenital Thrombotic Thrombocytopenic Purpura
-
-
-
-
-
-
-
Ionis (IONS) presents positive results from OASIS-HAE and OASISplus studies of investigational medicine donidalorsen in patients with hereditary angioedema
-
-
-
-
-
-
-
Galapagos NV (GLPG) and Adaptimmune (ADAP) Enter Collaboration Agreement Over uza-cel
-
-
-
-
-
-
-
Candel Therapeutics (CADL) Granted FDA Orphan Drug Designation for CAN-3110
-
-
-
-
-
-
-
ATARA Biotherapeutics (ATRA) Presents Preclinical Data on ATA3219
-
-
-
-
-
-
-
Biohaven Pharma (BHVN) Falls 31% Following Updates from Annual Investor R&D Day
-
-
-
-
-
-
-
PMV Pharmaceuticals (PMVP) and Foundation Medicine Collaborate to Develop Companion Diagnostic for Rezatapopt
-
67,236 total articles have been posted to this category.
Sign-up to StreetInsider.com Premium
to see all today's market moving FDA reports.